课题基金 / 基金详情

MN/CA9 expression and VHL regulation in renal cell carcinoma

MN/CA9 expression and VHL regulation in renal cell carcinoma
肾细胞癌中MN/CA9的表达及VHL调控
批准号:
14571515
负责人:
UEMURA Hirotsugu
金额:
$2.24万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2002
资助国家:
日本
项目状态:
已结题
起止时间:
2002 至 2003

项目摘要

项目成果

UEMURA Hirotsugu的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The von Hippel-Lindaw (VHL) gene is a well-known tumor suppressor gene interacting with the hypoxia inducible factor (HIF), which associates with a variety of gene expressions in normal and cancer cells. Frequent gene alterations of the VHL gene, such as deletions or mutations, have been reported in sporadic renal cell carcinoma (RCC), suggesting one of major cause of RCC development. MN/CA9, which is one of the isoenzymes of the carbonic anhydrase family, is frequently over-expressed and considered as a tumor-associated antigen in RCCs. We have previously demonstrated that the RCC cell lines with wild-type VHL gene expression have undetectable or extremely low expressions of MN/CA9 so that the VHL gene alterations may have a role for the MN/CA9 constitutive expression in RCCs. Since the fact that the MN/CA9 expression was induced by hypoxic condition, the VHL-HIF pathway may associate with the MN/CA9 gene regulation in RCCs. To investigate the role of MN/CA9 in VHL-HIF pathway, 6 RCC cell lines were analyzed for MN/CA9 mRNA expression. Despite all these cell lines have the VHL gene alterations, 3 of 6 lines have no expression of MN/CA9. We used other 3 cell lines expressing MN/CA9 for further analysis of VHL-related hypoxia. In nonnoxic condition, the transfectants with the VHL expression vector in these 3 cell lines showed down-regulation of MN/CA9 expression compared to the transfectants with control vector or parental cells. In hypoxic condition, however theMN/CA9 expression was induced in these transfectants with the VHL gene, but not in the control transfectants or parental cells. Furthermore, we used MN/CA9-negative cell line SK-RC 14, which has the VHL gene deletion, to investigate whether MN/CA9-negative cell line can induce MN/CA9 expression in either normoxic or hypoxic condition through VHL dependent pathway. SK-RC14 did not show any induction of MN/CA9. This study demonstrates that regulation of MN/CA9 is not exactly associated with pVHL.
期刊论文(34)
专著(0)
科研奖励(0)
会议论文
K Shimizu, H Uemura et al.: "Induction of antigen specific cellular immunity by vaccination with peptides from MN/CAIX in renal cell carcinoma(学位論文)"Oncol Report. 10(5). 1307-1311 (2003)
K Shimizu、H Uemura 等人:“在肾细胞癌中通过接种来自 MN/CAIX 的肽来诱导抗原特异性细胞免疫(论文)”Oncol Report 10(5) (2003)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
K Gramajer, M deWeijert, H Uemura et al.: "Renal cell carcinoma-associated methylation and expression : in vivo and in vitro studies"Urology. 60. 357-362 (2002)
K Gramajer、M deWeijert、H Uemura 等人:“肾细胞癌相关甲基化和表达:体内和体外研究”泌尿学。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
K Gramaier, M Deweijert, H Uemura, J Schalken, E Oosterwijk: "Renal cellcarcinoma-associated methylation and expression: in vivo and in vitro studies"Urology. 60. 357-362 (2002)
K Gramaier、M Deweijert、H Uemura、J Schalken、E Oosterwijk:“肾细胞癌相关甲基化和表达:体内和体外研究”泌尿学。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
植村天受, 平尾佳彦: "流血中陣癌細胞の検出方法と臨床的意義"癌と化学療法. 29(10). 1712-1718 (2002)
Tenke Uemura、Yoshihiko Hirao:“血性 Nakajin 癌细胞的检测方法和临床意义”Cancer and Chemotherapy 29(10) (2002)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
14
    Development of the HLA-A2 restricted multi-peptides vaccine for renal cell carcinoma.
    • 批准号:
      16H05466
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.07万
    • 财政年份:
      2016
    • 负责人:
      UEMURA Hirotsugu
    • 依托单位:
    Functional analysis of autophagy in PTEN/Atg7 double knockout mouse prostate cancer
    • 批准号:
      26670707
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.33万
    • 财政年份:
      2014
    • 负责人:
      UEMURA Hirotsugu
    • 依托单位:
    Development of multi-peptide tumor vaccine for renal cell carcinoma
    • 批准号:
      25293336
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.56万
    • 财政年份:
      2013
    • 负责人:
      UEMURA Hirotsugu
    • 依托单位:
    Development of tailor made peptide vaccines for renal cell carcinoma
    • 批准号:
      22390305
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $12.23万
    • 财政年份:
      2010
    • 负责人:
      UEMURA Hirotsugu
    • 依托单位:
    国内基金
    海外基金
    新型生物α-Mn2O3酶促合成及其新污染物高级氧化研究
    • 批准号:
      2026JJ80061
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      李丁
    • 依托单位:
    3D打印Fe/Mn双组分多层孔道电极电化学靶向回收浮选复合废水中Sb(V)的机理研究
    • 批准号:
      2026JJ50213
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      侯保林
    • 依托单位:
    尖晶石型Li₁.₃₃Mn₁.₆₇O₄中Li⁺/H⁺界面交换动力学机理与锰溶损靶向钝化机制研究
    高效全天候催化体系处理核电厂有机废液中51Cr/54Mn的机制研究
    • 批准号:
      2026JJ80233
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      谢超
    • 依托单位: